OsteoFlo HydroFiber Ambispective Evaluation
Part of paid clinical trials in Naperville, Illinois.
- Sponsor
- SurGenTec LLC
- Study ID
- NCT07784673
- Status
- Enrolling By Invitation
Conditions
- OsteoFlo HydroFiber
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- OsteoFlo HydroFiber — DEVICEObservational study of subjects previously implanted with OsteoFlo HydroFiber.
Study Details
The goal of this observational, ambispective study is to collect real world patient outcomes to characterize the safety and effectiveness of OsteoFlo HydroFiber when used to promote fusion in the lumbar spine.
Key Dates
- First listed
- Aug 25, 2026
- Start date
- Sep 1, 2026
- Status verified
- Aug 2026
- Primary completion
- Feb 1, 2027
- Completion
- Feb 1, 2027
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: LumbarPreviously implanted with the OsteoFlo HydroFiber in one or two contiguous vertebral levels of the lumbar spine (L1-S1).
Primary Outcome Measure
Rate of Qualitative Fusion [ Time Frame: 6 months post-op ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Duly Health and Care | Naperville | Illinois | 60540 | - |
| Orthopaedics Northeast | Fort Wayne | Indiana | 46825 | - |